Norway
· Delayed Price · Currency is NOK Arctic Bioscience AS Statistics
Total Valuation
Arctic Bioscience AS has a market cap or net worth of NOK 52.77 million. The enterprise value is 34.70 million.
| Market Cap | 52.77M |
| Enterprise Value | 34.70M |
Important Dates
The next estimated earnings date is Friday, November 29, 2024.
| Earnings Date | Nov 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Arctic Bioscience AS has 25.37 million shares outstanding. The number of shares has increased by 1.32% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 25.37M |
| Shares Change (YoY) | +1.32% |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | 18.57% |
| Owned by Institutions (%) | 12.16% |
| Float | 8.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.65 |
| PB Ratio | 0.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.72 |
| EV / Sales | 1.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.58 |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.06 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | -27.46 |
Financial Efficiency
Return on equity (ROE) is -18.66% and return on invested capital (ROIC) is -11.96%.
| Return on Equity (ROE) | -18.66% |
| Return on Assets (ROA) | -10.55% |
| Return on Capital (ROIC) | -11.96% |
| Revenue Per Employee | 1.88M |
| Profits Per Employee | -2.85M |
| Employee Count | 355 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 0.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.07% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -74.07% |
| 50-Day Moving Average | 7.09 |
| 200-Day Moving Average | 9.77 |
| Relative Strength Index (RSI) | 31.09 |
| Average Volume (20 Days) | 210,149 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Arctic Bioscience AS had revenue of NOK 31.88 million and -48.37 million in losses. Loss per share was -1.91.
| Revenue | 31.88M |
| Gross Profit | 9.64M |
| Operating Income | -50.19M |
| Pretax Income | -48.37M |
| Net Income | -48.37M |
| EBITDA | -48.50M |
| EBIT | -50.19M |
| Loss Per Share | -1.91 |
Balance Sheet
The company has 19.83 million in cash and 1.77 million in debt, giving a net cash position of 18.06 million or 0.71 per share.
| Cash & Cash Equivalents | 19.83M |
| Total Debt | 1.77M |
| Net Cash | 18.06M |
| Net Cash Per Share | 0.71 |
| Equity (Book Value) | 235.09M |
| Book Value Per Share | 9.27 |
| Working Capital | 38.40M |
Cash Flow
In the last 12 months, operating cash flow was -38.17 million and capital expenditures -21.88 million, giving a free cash flow of -60.05 million.
| Operating Cash Flow | -38.17M |
| Capital Expenditures | -21.88M |
| Free Cash Flow | -60.05M |
| FCF Per Share | -2.37 |
Margins
Gross margin is 30.23%, with operating and profit margins of -157.42% and -151.72%.
| Gross Margin | 30.23% |
| Operating Margin | -157.42% |
| Pretax Margin | -151.72% |
| Profit Margin | -151.72% |
| EBITDA Margin | -152.13% |
| EBIT Margin | -157.42% |
| FCF Margin | -188.35% |
Dividends & Yields
Arctic Bioscience AS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.32% |
| Shareholder Yield | -1.32% |
| Earnings Yield | -91.86% |
| FCF Yield | -113.79% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |